Sign inJoin waitlistJoin the waitlist

JK

Jonathan Kolitz

Physician · Long Island Jewish Medical Center - Northwell Health

Credentials: · · · · ·

History

Long Island Jewish Medical Center - Northwell Health
2021–Present

Hematology and Medical Oncology
1982–1985
Internal Medicine
1979–1982
Yale Univ Sch of Med
1975–1979

Research

Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia
Blood · 1999 · 1,994 citations
CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid…
Journal of Clinical Oncology · 2018 · 802 citations
Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia
New England Journal of Medicine · 2000 · 780 citations

CB
Clara Bloomfield
90 papers
Bayard Powell
89 papers
Richard Larson
71 papers
Richard Stone
65 papers
SA
Steven Allen
57 papers
Guido Marcucci
54 papers
KR
Kanti Rai
47 papers
JB
John Byrd
46 papers
Nicholas Chiorazzi
42 papers
MC
Michael Caligiuri
41 papers
Maria Baer
40 papers
Joseph Moore
31 papers

Clinical trials

Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
Principal investigator · Completed · Phase 2
Jazz Pharmaceuticals
2009–2012
Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer.
Principal investigator · Completed · Phase 1
Jazz Pharmaceuticals
2006–2009
Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML
Principal investigator · Completed · Phase 2
Eleos, Inc.
2004–2007
Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia
Study chair · Completed · Phase 1, Phase 2
National Cancer Institute (NCI)
1997–2010